Publications
Export 13 results:
Filters: Author is Soucy, Geneviève [Clear All Filters]
“Monoclonal full-length antibody against TAR DNA-binding protein 43 reduces related proteinopathy in neurons.”, JCI Insight, 2020.
, “Transmission of ALS pathogenesis by the cerebrospinal fluid”, Acta neuropathologica communications, vol. 8, no. 1, pp. 65 - 65, 2020.
, “Transmission of ALS pathogenesis by the cerebrospinal fluid.”, Acta Neuropathol Commun, vol. 8, no. 1, p. 65, 2020.
, “Virus-mediated delivery of antibody targeting TAR DNA-binding protein-43 mitigates associated neuropathology.”, J Clin Invest, vol. 129, no. 4, pp. 1581-1595, 2019.
, “Exosome secretion is a key pathway for clearance of pathological TDP-43.”, Brain, vol. 139, no. Pt 12, pp. 3187-3201, 2016.
, “IL-10 Controls Early Microglial Phenotypes and Disease Onset in ALS Caused by Misfolded Superoxide Dismutase 1.”, J Neurosci, vol. 36, no. 3, pp. 1031-48, 2016.
, “Sex-dependent effects of chromogranin B P413L allelic variant as disease modifier in amyotrophic lateral sclerosis.”, Hum Mol Genet, 2016.
, “Sex-dependent effects of chromogranin B P413L allelic variant as disease modifier in amyotrophic lateral sclerosis.”, Hum Mol Genet, vol. 25, no. 21, pp. 4771-4786, 2016.
, “Adeno-associated virus-mediated delivery of a recombinant single-chain antibody against misfolded superoxide dismutase for treatment of amyotrophic lateral sclerosis.”, Mol Ther, vol. 22, no. 3, pp. 498-510, 2014.
, “Loss of glial neurofascin155 delays developmental synapse elimination at the neuromuscular junction.”, J Neurosci, vol. 34, no. 38, pp. 12904-18, 2014.
, “Ablation of proliferating cells in the CNS exacerbates motor neuron disease caused by mutant superoxide dismutase.”, PLoS One, vol. 7, no. 4, p. e34932, 2012.
, “Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS.”, J Neurochem, vol. 113, no. 5, pp. 1188-99, 2010.
, “Absence of tumor necrosis factor-alpha does not affect motor neuron disease caused by superoxide dismutase 1 mutations.”, J Neurosci, vol. 26, no. 44, pp. 11397-402, 2006.
,